You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 2, February 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Surgical Physiology, Other
 •Prognosis/ Outcomes
 •Alert me on articles by topic

G Protein {gamma}7 Expression as a New Clinicopathological Marker in Patients With Intrahepatic Cholangiocarcinoma

Tohru Utsunomiya, MD; Hiroshi Inoue, MD; Ken-Ichi Taguchi, MD; Mitsuo Shimada, MD; Keizo Sugimachi, MD; Masaki Mori, MD

Arch Surg. 2002;137:181-185.

Hypothesis  The signal alterations mediated by small G proteins such as Ras, Rho, and Rac have been reported in several cancers. The human G protein {gamma}7 (G-{gamma}7) gene, which is down-regulated in various digestive organ cancers, was recently identified and cloned. Thus, the G-{gamma}7–coupled heterotrimeric G proteins may also contribute to carcinogenesis in human cancers.

Setting  University hospital and medical institute of bioregulation.

Patients and Methods  The clinicopathological significance of G-{gamma}7 expression in 18 patients with intrahepatic cholangiocarcinoma (IHCC) was examined. The tumor-nontumor ratio of G-{gamma}7 expression was determined using reverse transcription polymerase chain reaction analysis. To visualize the localization of G-{gamma}7, an immunohistochemical study was performed.

Main Outcome Measure  Clinicopathological significance of G-{gamma}7 expression in human IHCC.

Results  Expression of G-{gamma}7 messenger RNA was lower in tumor tissue than in the corresponding nontumor tissue in 17 (94%) of 18 patients with IHCC. The mean tumor-nontumor ratio was 0.54. Eleven patients with tumor-nontumor ratios less than 0.5 showed significantly poorer differentiated IHCC than 7 with tumor-nontumor ratios of 0.5 and greater (P<.01). Decreased expression of G-{gamma}7 protein in the carcinoma tissue, especially in the poorly differentiated IHCC tissue, was confirmed using immunohistochemical staining.

Conclusions  Reduced expression of G-{gamma}7 is associated with the histological grade of IHCC and may therefore prove to be a useful marker for predicting the biological aggressiveness of human IHCC.


From the Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan (Drs Utsunomiya, Inoue, and Mori); and the Departments of Anatomic Pathology (Dr Taguchi) and Surgery and Science (Drs Shimada and Sugimachi), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tripartite Motif-Containing 29 (TRIM29) Isa Novel Marker for Lymph Node Metastasis in Gastric Cancer
Kosaka et al.
Ann. Surg. Oncol. 2007;14:2543-2549.
ABSTRACT | FULL TEXT  

Expression of Cancer-Testis Antigen (CTA) Genes in Intrahepatic Cholangiocarcinoma
Utsunomiya et al.
Ann. Surg. Oncol. 2004;11:934-940.
ABSTRACT | FULL TEXT  

Cystatin-like Metastasis-associated Protein mRNA Expression in Human Colorectal Cancer Is Associated with Both Liver Metastasis and Patient Survival
Utsunomiya et al.
Clin. Cancer Res. 2002;8:2591-2594.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.